Laurent Gregoire
Quebec, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 07, 2017
Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
Journal: Biochemical pharmacology
Published: February 05, 2016
Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys.
Journal: Brain structure & function
Published: July 17, 2015
Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Journal: Journal of neurosurgery
Published: May 02, 2015
Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
Journal: Neuropharmacology
Published: March 23, 2015
mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias.
Journal: Current neuropharmacology
Published: March 04, 2015
Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.
Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.
Journal: Behavioural brain research
Published: December 16, 2014
Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: May 19, 2014
Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys.
Journal: Experimental neurology
Published: April 30, 2014
AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys.
Journal: Parkinsonism & related disorders
Published: February 12, 2014
Last Updated: 09/26/2026